AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

ERYTECH Pharma S.A.

Declaration of Voting Results & Voting Rights Announcements Mar 7, 2017

1295_dva_2017-03-07_8243d852-07c9-4b18-85b2-3c24065b5b88.pdf

Declaration of Voting Results & Voting Rights Announcements

Open in Viewer

Opens in native device viewer

Information related to total number of voting rights and shares composing the share capital – February 2017

Article 223-16 of general regulation of French Autorité des Marchés Financiers Lyon - France

Listing market: Euronext Paris from Euronext Market segment : segment C

ISIN Code : FR0011471135

website : www.erytech.com

Date Total of shares composing
the share capital
Total of brut(1) voting
rights
Total of net(2) voting
rights
01 January 2017 8 732 648 10 410 050 10 407 550
28 February 2017 8 732 648 10 395 830 10 393 330

(1) Gross voting rights number (or « theoretical » voting rights) is used as a calculus base for the crossing of the threshold. In accordance with article 223-11 of general regulation of Autorité des Marchés Financiers, this number is calculated on the basis of all shares carrying the single and double voting rights, including shares without voting rights.

(2) Without treasury shares

Talk to a Data Expert

Have a question? We'll get back to you promptly.